Proheart 12 Patent Expiration

Exclusivity Information

Proheart 12 holds 1 exclusivity out of which 1 has expired. Details of Proheart 12's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Jul 02, 2022

About Proheart 12

Proheart 12 is a drug owned by ZOETIS INC. Proheart 12 uses Moxidectin as the active ingredient.

Active Ingredient:

Proheart 12 uses Moxidectin as the active ingredient. Check out other Drugs and Companies using Moxidectin ingredient.